• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, November 16, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Sub400 Protocol Cross-Linking Stabilized Keratoconus in Most Thin Corneas at One Year

by
November 12, 2026
in Health
Reading Time: 3 mins read
0
Sub400 Protocol Cross-Linking Stabilized Keratoconus in Most Thin Corneas at One Year

Sub400 Protocol Cross-Linking Stabilized Keratoconus in Most Thin Corneas at One Year

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A specialized corneal cross-linking procedure known as the Sub400 protocol successfully halted disease progression in 81 percent of treated keratoconus eyes with stromal thickness below 400 micrometers after 12 months of follow-up, according to research published in BMC Ophthalmology. The non-randomized interventional case series evaluated 21 eyes from 17 patients presenting with progressive keratoconus whose intraoperative stromal thickness fell below the traditional threshold required for conventional treatment protocols.

Patients experiencing progressive keratoconus typically face substantial therapeutic hurdles when their corneal stromal thickness measures under 400 micrometers at the time of ultraviolet-A irradiation.

Following epithelial removal, the clinical team administered ultraviolet-A light at an intensity of 3 milliwatts per square centimeter. Rather than using a uniform irradiation interval, exposure times were selected from the original Sub400 nomogram based on the post-soak stromal thickness measured during the operation.

Patient outcomes were tracked across multiple clinical parameters before intervention and at a 12-month follow-up evaluation. Assessments included corrected distance visual acuity, optical refraction, Scheimpflug tomography, anterior-segment optical coherence tomography, and endothelial cell density. Nonprogression was defined prior to analysis as an increase in maximum keratometry of less than 1.0 diopter at the one-year mark.

The study found that 17 of the 21 evaluated eyes met the prespecified nonprogression criterion after one year. Across all treated eyes, the mean change in maximum keratometry was 0.36 plus or minus 2.45 diopters, representing a difference that was not statistically significant. Concurrently, the mean spherical equivalent demonstrated an improvement, shifting from minus 6.30 plus or minus 3.98 diopters preoperatively to minus 4.43 plus or minus 4.40 diopters at the 12-month evaluation.

Examination of the deeper corneal architecture revealed a visible stromal demarcation line in 17 eyes, situated at a mean depth of 215.18 plus or minus 24.78 micrometers. Statistical analyses indicated that the depth of this demarcation line did not correlate with baseline thinnest corneal thickness, changes in endothelial cell density, or changes in maximum keratometry. In addition, exploratory comparisons between the four eyes with continuing progression and the 17 stabilized eyes identified no significant baseline demographic or clinical differences, though statistical power was restricted by cohort size.

Endothelial health assessments showed no instances of clinical corneal decompensation or endothelial failure throughout the study duration. However, laboratory measurements revealed a statistically significant reduction in endothelial cell density in treated eyes, declining from 2596 plus or minus 269 cells per square millimeter to 2568 plus or minus 285 cells per square millimeter. A parallel reduction was also recorded in untreated fellow eyes, where cell counts dropped from 2613 plus or minus 259 to 2567 plus or minus 261 cells per square millimeter.

The authors emphasized that the observed endothelial cell reduction warrants cautious interpretation given the small, uncontrolled nature of the study cohort. Furthermore, individual intraoperative pachymetry measurements, specific exposure durations, and total delivered fluences could not be recovered for analysis, preventing independent verification of eye-specific nomogram adherence or validation of the proposed depth-control mechanism. Consequently, larger controlled clinical studies with complete procedural documentation and extended follow-up remain essential to verify long-term endothelial safety and comparative efficacy.

Subject of Research: Clinical outcomes of Sub400 corneal cross-linking in progressive keratoconus with thin corneas

Article Title: Corneal cross-linking using the Sub400 protocol in keratoconus patients with corneal thickness less than 400 μm

Article References: Hashemian, H., Khodaparast, M., Afshar, P., Koorehpaz, K., Esfandiari, H., Omer, M., Daneshvar, K., & Khorrami-Nejad, M. (2026). Corneal cross-linking using the Sub400 protocol in keratoconus patients with corneal thickness less than 400 μm. BMC Ophthalmology. https://doi.org/10.1186/s12886-026-05516-y

Image Credits: AI Generated

DOI: 10.1186/s12886-026-05516-y

Keywords: keratoconus, corneal cross-linking, Sub400 protocol, corneal thickness, stroma, ophthalmology, ultraviolet-A irradiation, maximum keratometry, endothelial cell density, Scheimpflug tomography, anterior segment OCT, demarcation line, refraction, spherical equivalent, corneal decompensation, interventional case series

News Source: Ophelia Keating. (November 12, 2026). Sub400 Protocol Cross-Linking Stabilized Keratoconus in Most Thin Corneas at One Year. Scienmag.

Tags: anterior segment OCTcorneal cross-linkingcorneal decompensationcorneal thicknessdemarcation lineendothelial cell densityinterventional case serieskeratoconusmaximum keratometryOphthalmologyrefractionScheimpflug tomographyspherical equivalentstromaSub400 protocolultraviolet-A irradiation
Share12Tweet7Share2ShareShareShare1

Related Posts

Review Finds Minimal Evidence Linking Gut Bacterial Vesicles to Steroid Bone Damage

Review Finds Minimal Evidence Linking Gut Bacterial Vesicles to Steroid Bone Damage

November 16, 2026
Rare Discordance Between DPYD HapB3 Markers Challenges Cancer Drug Phenotype Predictions

Rare Discordance Between DPYD HapB3 Markers Challenges Cancer Drug Phenotype Predictions

November 16, 2026

Significant Liver Fibrosis Linked to Age and Liver Enzymes in Diabetes Study

November 16, 2026

Daily Adolescent Vigorous Activity Declined Across Twelve Years in Thirty-Four Countries

November 16, 2026

POPULAR NEWS

  • Higher Serum Uric Acid Associated With Obesity in Children With Tonsillar Hypertrophy

    Higher Serum Uric Acid Associated With Obesity in Children With Adenoid and/or Tonsillar Hypertrophy

    29 shares
    Share 12 Tweet 7
  • Clonal Haematopoiesis Associated With Elevated Cardiovascular Risk in MASLD Cohort

    29 shares
    Share 12 Tweet 7
  • Resting-state Brain Age Links Neurodevelopmental Burden to Schizophrenia Severity

    29 shares
    Share 12 Tweet 7
  • Low Preoperative Nutritional Index Predicts ICU Admission After Orthopedic Surgery

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Review Finds Minimal Evidence Linking Gut Bacterial Vesicles to Steroid Bone Damage

Rare Discordance Between DPYD HapB3 Markers Challenges Cancer Drug Phenotype Predictions

Significant Liver Fibrosis Linked to Age and Liver Enzymes in Diabetes Study

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 87 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.